News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IDEXX Laboratories (IDXX) To Release 2004 Second Quarter Financial Results



10/19/2005 5:09:00 PM

WESTBROOK, Maine, July 15 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. , has scheduled the release of its 2004 second quarter financial results for Friday, July 23, at approximately 7:00 a.m. (eastern). The Company will conduct an analyst conference call beginning at 8:30 a.m. (eastern) on that day.

Individuals can access a live Webcast of the conference call through a link on the home page of the IDEXX Web site, idexx.com. An archived edition of the call will be available after 1:00 p.m. (eastern) via the same link.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 719-457-2630 and reference conference call number 725670. Replay of the conference call will be available as of 12:00 p.m. (eastern) through Friday, July 30, by dialing 719-457-0820 and referencing conference call number 725670.

IDEXX Laboratories, Inc., is a worldwide leader in the development and commercialization of innovative, technology-based products and services for veterinary, food and water applications. The Company's largest business is focused on companion animal health, combining biotechnology, medical device technology and information technology to aid veterinarians in providing better medicine while building successful practices. IDEXX Laboratories' food and water businesses are focused on employing innovative technologies to monitor production animal health and the safety and quality of drinking water and milk. Headquartered in Westbrook, Maine, IDEXX Laboratories employs more than 2,500 people and offers products to customers in over 100 countries.

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations of future events, which are subject to risks and uncertainties. If underlying assumptions prove inaccurate, actual results could vary materially from management's expectations. Risks and uncertainties include timing and success of new product introductions, competition and technological change, government regulation and obtaining government approvals, product demand and market acceptance of products, availability of products and raw materials, and litigation. A further description of these risks and uncertainties and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2003, and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2004, in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations." The Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments.

Contact: Bonnie Reid, Investor Relations, (207) 856-0548

Photo: http://www.newscom.com/cgi-bin/prnh/20030305/IDEXXLOGOPR Newswire Photo Desk, 888-776-6555 or 201-369-3467 IDEXX Laboratories, Inc.

CONTACT: Bonnie Reid, Investor Relations of IDEXX Laboratories, Inc.,+1-207-856-0548


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES